# Pilot of Letrozole for Uterine Myomas

> **NCT02470741** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 12 (actual)

## Conditions studied

- Leiomyoma
- Uterine Fibroids

## Interventions

- **DRUG:** Letrozole
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02470741
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02470741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02470741, "Pilot of Letrozole for Uterine Myomas". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02470741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*